Anthem Biosciences IPO: Strong Start with Big Names Backing It!

IPO Details: • Total Issue Size: ₹3,395 Cr (100% Offer for Sale – no fresh issue) • IPO Opens: July 14 • IPO Closes: July 16 • Price: ₹570 per share Anchor Investors Show Strong Confidence: On July 11, Anthem Biosciences raised ₹1,016.02 Cr from 60 top institutional investors through the anchor book, a day ahead of IPO opening. Key Highlights: • 1.78 crore shares allocated at ₹570/share • ₹1,016 Cr raised via anchor book • 59.5% (1.06 Cr shares) of anchor allocation went to 18 Indian mutual funds through 33 schemes Big Global Names Participated: • Abu Dhabi Investment Authority • Government Pension Fund Global (Norway) • Amundi, PineBridge, Eastspring, Societe Generale, and others Top Indian Mutual Funds Invested (~₹604.4 Cr): • HDFC MF, ICICI Pru, Kotak, Nippon, Axis, Aditya Birla, UTI, Mirae, Franklin, Motilal Oswal, Quant, and more Insurance Giants Also Participated: • ICICI Prudential Life • Tata AIA Life • Axis Max Life • Bajaj Allianz Life What’s Anthem Biosciences? Bengaluru-based contract research & manufacturing (CDMO) company — serving global pharma & biotech firms. Bottom Line: This IPO has attracted strong domestic & global institutional interest, especially from mutual funds. It signals high confidence in the company's business model and future potential. Stay tuned if you're eyeing this IPO.